ArticleScience advances2016

An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.

Johnny Habchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.